Effect of Safinamide on Parkinson's Disease Related Chronic Pain
Status:
Completed
Trial end date:
2021-05-03
Target enrollment:
Participant gender:
Summary
This is a Phase IV, international, multicentre, randomised, double-blind, placebo controlled
study in IPD patients, experiencing motor fluctuations and PD related chronic pain while on
stable doses of levodopa (L-Dopa).
Participants will be randomized 2:1 to receive either active or placebo